BeOne Medicines (ONC) Amortizatization of Intangibles (2018 - 2019)

BeOne Medicines' (ONC) quarterly Amortizatization of Intangibles came in at -$51000.0 in Q3 2019, up 98.85% year-on-year from -$25647.3 in Q3 2018, and up 95.9% on a QoQ basis from -$1.2 million in Q2 2019.

BeOne Medicines (ONC) Amortizatization of Intangibles (2018 - 2019) Analysis & Trends

BeOne Medicines (ONC) has 2 years of Amortizatization of Intangibles data on file, last reported at -$51000.0 in Q3 2019.

  • On a quarterly basis, Amortizatization of Intangibles rose 98.85% year-over-year to -$51000.0 in Q3 2019; TTM through Sep 2019 was -$7.3 million, a 64.29% decrease from a year earlier, with the FY2018 full-year figure at -$8.0 million, changed N/A from the prior year.
  • Amortizatization of Intangibles for Q3 2019 stood at -$51000.0, up from -$1.2 million in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for ONC reached as high as -$51000.0 in Q3 2019 and fell as low as -$4.4 million in Q3 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Alnylam Pharmaceuticals 37.29 Bn 34.28 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2019 -51,000.00
Sep 30, 2019 -51,000.00
Jun 30, 2019 -1.24 Mn
Jun 30, 2019 -1.24 Mn
Mar 31, 2019 -2.41 Mn
Mar 31, 2019 -2.41 Mn
Dec 31, 2018 -3.59 Mn
Dec 31, 2018 -3.59 Mn
Sep 30, 2018 -4.44 Mn
Sep 30, 2018 -4.44 Mn